Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

The Faculty of Medicine - Developmental Biology and Cancer Research: Schlesinger Michael


 Last updated June 2021 - School of Pharmacy

List of Publications

(1) Schlesinger N, Schlesinger M. Previously reported prior studies of cherry juice concentrate for gout flare prophylaxis: Comment on the article by Zhang et al. Arthritis Rheum 2013;65(4):1135-1136.

(2) Granot E, Jakobovich E, Rabinowitz R, Levy P, Schlesinger M. DHA supplementation during pregnancy and lactation affects infants' cellular but not humoral immune response. Mediators Inflamm 2011;2011.

(3) Gazit R, Hershko K, Ingbar A, Schlesinger M, Israel S, Brautbar C, et al. Immunological assessment of familial tinea corporis. J Eur Acad Dermatol Venereol 2008;22(7):871-874.

(4) Kogan NM, Schlesinger M, Peters M, Marincheva G, Beeri R, Mechoulam R. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: A comparative in vivo study. J Pharmacol Exp Ther 2007;322(2):646-653.

(5) Kogan NM, Schlesinger M, Priel E, Rabinowitz R, Berenshtein E, Chevion M, et al. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. Mol Cancer Ther 2007;6(1):173-183.

(6) Kogan NM, Blázquez C, Álvarez L, Gallily R, Schlesinger M, Guzmán M, et al. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. Mol Pharmacol 2006;70(1):51-59.

(7) Schlesinger N, Schlesinger M, Seshan SV. Seasonal variation of lupus nephritis: High prevalence of class V lupus nephritis during the winter and spring. J Rheumatol 2005;32(6):1053-1057.

(8) Kogan NM, Rabinowitz R, Levi P, Gibson D, Sandor P, Schlesinger M, et al. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. J Med Chem 2004;47(15):3800-3806.

(9) Yu Y, Rabinowitz R, Steinitz M, Schlesinger M. Correlation between the expression of CD4 and the level of CD4 mRNA in human B-cell lines. Cell Immunol 2002;215(1):78-86.

(10) Yu Y, Rabinowitz R, Polliack A, Ben-Bassat H, Schlesinger M. Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells. Eur J Haematol 2002;68(1):22-30.

(11) Shapira-Nahor O, Maayan S, Peden KWC, Rabinowitz R, Schlesinger M, Alian A, et al. Replication of HIV-1 deleted Nef mutants in chronically immune activated human T cells. Virology 2002;303(1):138-145.

(12) Rubnov S, Kashman Y, Rabinowitz R, Schlesinger M, Mechoulam R. Suppressors of cancer cell proliferation from fig (Ficus carica) resin: Isolation and structure elucidation. J Nat Prod 2001;64(7):993-996.

(13) Ermolina I, Polevaya Y, Feldman Y, Ginzburg B-, Schlesinger M. Study of normal and malignant white blood cells by time domain dielectric spectroscopy. IEEE Trans Dielectr Electr Insul 2001;8(2):253-261.

(14) Rabinowitz R, Yongmao Y, Belov E, Shubinsky G, Ben-Bassat H, Schlesinger M. Regulation of the expression of CD45 isoforms in the Farage human B cell lymphoma line and its 10.6.1 subline. Leuk Lymphoma 2001;41(5-6):643-654.

(15) Schlesinger M, Jiang J-, Roboz JP, Denner L, Ling Y-, Holland JF, et al. 3-m-bromoacetylamino benzoic acid ethyl ester: A new cancericidal agent that activates the apoptotic pathway through caspase-9. Biochem Pharmacol 2000;60(11):1693-1702.

(16) Yu Y, Rabinowitz R, Polliack A, Ben-Bassat H, Schlesinger M. B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule. Eur J Haematol 2000;64(6):376-384.

(17) Nagler A, Rabinowitz R, Rosengolts-Rat J, Condiotti R, Schlesinger M. Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT). J Hematother Stem Cell Res 2000;9(1):63-75.

(18) Czerninski R, Katz J, Schlesinger M. Preliminary evidence for an association of measles virus with recurrent aphthous ulceration [3]. Arch Dermatol 2000;136(6):801-803.

(19) Fridlender ZG, Rabinowitz R, Schlesinger M. Monocytes confer CD14 antigenicity on activated lymphocytes. Hum Immunol 1999;60(11):1028-1038.

(20) Polevaya Y, Ermolina I, Schlesinger M, Ginzburg B-, Feldman Y. Time domain dielectric spectroscopy study of human cells II. Normal and malignant white blood cells. Biochim Biophys Acta Biomembr 1999;1419(2):257-271.

(21) Granot E, Rabinowitz R, Schlesinger M. Lymphocyte subset profile of young healthy children residing in a rural area: Possible role of recurrent gastrointestinal infections. J Pediatr Gastroenterol Nutr 1999;28(2):147-151.

(22) Gabay C, Ben-Bassat H, Schlesinger M, Laskov R. Somatic mutations and intraclonal variations in the rearranged V(K) genes of B-non-Hodgkin's lymphoma cell lines. Eur J Haematol 1999;63(3):180-191.

(23) Nagler A, Condiotti R, Rabinowitz R, Schlesinger M, Nguyen M, Terstappen LWMM. Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC). Med Oncol 1999;16(3):177-187.

(24) Bishara A, Aker M, Amar A, Brautbar C, Schlesinger M, Rabinowitz R, et al. Enhanced lymphoid cell recovery after bone marrow transplantation: Correlation with the presence of costimulatory antibodies in serum. Exp Hematol 1998;26(7):580-587.

(25) Krifuks O, Bergelson LD, Schlesinger M. The down-modulation of CD4 induced by the GM1 ganglioside is regulated by phosphatases and kinases: Evidence from enzyme inhibitors and anti-CD45 antibodies. Cell Immunol 1998;187(1):45-51.

(26) Rabinowitz R, Pokroy R, Yu Y, Schlesinger M. Activated human T-cells bestow T-cell antigens to non-T-cells by intercellular antigen transfer. Hum Immunol 1998;59(6):331-342.

(27) Rosenmann E, Rabinowitz R, Schlesinger M. Lymphocyte subsets in human tonsils: The effect of age and infection. Pediatr Allergy Immunol 1998;9(3):161-167.

(28) Zalkind M, Calderon Y, Rabinowitz R, Hadar R, Schlesinger M. The effect of dental alloys on mouse lymphocyte subpopulations. J Oral Rehabil 1998;25(2):106-109.

(29) Freier S, Kerem E, Dranitzki Z, Schlesinger M, Rabinowitz R, Brautbar C, et al. Hereditary CD4+ T lymphocytopenia. Arch Dis Child 1998;78(4):371-372.

(30) Rabinowitz R, Hadar R, Schlesinger M. The appearance of the CD4+CD8+ phenotype on activated T cells: Possible role of antigen transfer. Hum Immunol 1997;55(1):1-10.

(31) Jiang JD, Schlesinger M, Sacks H, Mildvan D, Roboz JP, Bekesi JG. Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical status. J Clin Immunol 1997;17(2):185-192.

(32) Shubinsky G, Schlesinger M. The CD38 lymphocyte differentiation marker: New insight into its ectoenzymatic activity and its role as a signal transducer. Immunity 1997;7(3):315-324.

(33) Granot E, Rabinowitz R, Schlesinger M. Peripheral blood lymphocyte subset profile of young children experiencing recurrent gastrointestinal infections simulates that of adults. J Pediatr Gastroenterol Nutr 1997;24(4):469.

(34) Shubinsky G, Schlesinger M, Polliack A, Rabinowitz R. Pathways Controlling the Expression of Surface CD21 (CR2) and CD23 (FcεIIR) Proteins in Human Malignant B Cells. Leuk Lymphoma 1997;25(42130):521-530.

(35) Nagler A, Condiotti R, Rabinowilz R, Schlesinger M, Nguyen M. Detection of minimal residual disease (MRD) following BMT by multi-parameter flow cytometry (MPFC). Exp Hematol 1996;24(9):1135.

(36) Shubinsky G, Schlesinger M. The mechanism of interleukin 4-induced down-regulation of CD38 on human B cells. Cell Immunol 1996;173(1):87-95.

(37) Lisin R, Ginzburg BZ, Schlesinger M, Feldman Y. Time domain dielectric spectroscopy study of human cells. I. Erythrocytes and ghosts. BIOCHIM BIOPHYS ACTA BIOMEMBR 1996;1280(1):34-40.

(38) Schlesinger M, Rabinowitz R, Levy P, Maayan S. The expression of CD8 on B lymphocytes in HIV-infected individuals. Immunol Lett 1996;50(1-2):23-27.

(39) Schlesinger M, Silverman LR, Jiang JD, Yagi MJ, Holland JF, Bekesi JG. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. J Clin Lab Immunol 1996;48(4):149-166.

(40) Schlesinger M. Subpopulations of lymphocytes and autoimmunity. Isr J Med Sci 1995;31(1):5-7.

(41) Rabinowitz R, Massiah E, Hadar R, Schlesinger M. In vitro activation leads to the binding of T-cell markers to the surface of B-lymphocytes. Clin Immunol Immunopathol 1995;76(2):148-154.

(42) Schlesinger M, Peters V, Jiang JD, Roboz JP, Bekesi JG. Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infection. Pediatr Res 1995;38(3):390-396.

(43) Shubinsky G, Schlesinger M. The effects of interleukin 4 on the cell cycle of a human B‐cell lymphoma line. Cell Prolif 1994;27(8):489-499.

(44) Shubinsky G, Schlesinger M. Kinetics of the pleiotropic effect of interleukin 4 on the surface properties of human b-lymphoma cells. Leuk Lymphoma 1994;15(3-4):333-340.

(45) Schlesinger M, Chu FN, Badamchian M, Jiang JD, Roboz JP, Goldstein AL, et al. A Distinctive Form of Soluble CD8 Is Secreted by Stimulated CD8+ Cells in HIV-1-Infected and High-Risk Individuals. Clin Immunol Immunopathol 1994;73(2):252-260.

(46) Shubinsky G, Ben-Bassat H, Schlesinger M. The effect of IL-4 on the phenotype of a human B-cell lymphoma line (Farage) lacking immunoglobulin expression. Immunol Lett 1993;36(1):37-42.

(47) Schlesinger M, Granot E, Rabinowitz R, Deckelbaum RJ. Peripheral blood lymphocyte subsets in infants with diarrhea with and without giardia lamblia infection. Pediatr Res 1993;33(1):15-18.

(48) Schlesinger M, Yodfat Y, Rabinowitz R, Bronner S, Kark JD. Psychosocial stress and NK cells among members of a communal settlement. ADV EXP MED BIOL 1993;335:247-254.

(49) Polliack A, Rabinowitz R, Leizerowitz R, Keren-zur Y, Schlesinger M. Myelomonocytic antigens are rarely expressed on b-lymphocytic leukemia cells. Leuk Lymphoma 1993;9(1-2):125-131.

(50) Schlesinger M, Rabinowitz R, Brenner T, Abramsky O, Schlesinger M. Changes in lymphocyte subsets in myasthenia gravis: Correlation with level of antibodies to acetylcholine receptor and age of patient. Neurology 1992;42(11):2153-2157.

(51) Rabinowitz R, Granot E, Deckelbaum R, Schlesinger M. Antigenic differences between subsets of peripheral blood lymphocytes differing in their right angle light scatter in flow cytometric analysis. Int Arch Allergy Immunol 1992;97(3):200-204.

(52) Leshem B, Dekel R, Bercovier H, Tchakirov R, Polacheck I, Zakay-Rones Z, et al. Cytokine-induced resistance to microbial infections in normal, immunosuppressed and bone marrow transplanted mice. Bone Marrow Transplant 1992;9(6):471-477.

(53) Isacson R, Kedar E, Barak V, Gazit Z, Yurim O, Kalichman I, et al. Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response. Immunol Lett 1992;33(2):127-134.

(54) Ben-Bassat H, Polliack A, Shlomai Z, Kohn G, Hadar R, Rabinowitz R, et al. Farage, a novel early b cell lymphoma cell line with trisomy 11. Leuk Lymphoma 1992;6(6):513-521.

(55) Schlesinger M, Yodfat Y. The impact of stressful life events on natural killer cells. Stress Med 1991;7(1):53-60.

(56) Rabinowitz R, Afik O, Schlesinger M. The effect of heating on the expression and function of CD-2 molecules on human T-lymphocytes. Thymus 1991;18(4):195-208.

(57) Rabinowitz R, Polliack A, Leizerowitz R, Keren-Zur Y, Schlesinger M. Expression of CD11a (LFA-1) on b-chronic lymphocytic leukemia and lymphoma cells: Correlation with cell surface immunoglobulin intensity and CD58 (LFA-3) expression. Leuk Lymphoma 1991;5(S1):59-64.

(58) Morecki S, Nabet C, Ackerstein A, Schlesinger M, Slavin S. The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells. Bone Marrow Transplant 1991;7(4):269-273.

(59) Abrahamov A, Schlesinger M. Absence of natural killer cells in a child with pure red blood cell aplasia. Am J Hematol 1990;35(4):258-262.

(60) Schlesinger M, Afik O, Loves O, Maayan S, Rabinowitz R. Changes in the level of soluble CD-2 molecules in the serum of HIV-infected individuals. Cancer Detect Prev 1990;14(3):347-351.

(61) Schlesinger M. The function of Thy-1. Immunol Ser 1989;45:589-606.

(62) Schlesinger M, Kincade PW. Treatment of mouse thymus cells with phosphatidylinositol-specific phospholipase C preferentially abrogates their reactivity with autoantibodies to the Thy-1 antigen. Cell Immunol 1989;119(1):22-29.

(63) Schlesinger M, Bar-Shavit Z, Hadar R, Rabinowitz R. Modulation of the expression of CD4 on HL-60 cells by exposure to 1,25-dihydroxyvitamin D3. Immunol Lett 1989;22(4):307-311.

(64) Rabinowitz R, Hadar R, Schlesinger M. Idiotype regulation of thymus autoantibodies. Immunology 1988;65(4):635-640.

(65) Yodfat Y, Schlesinger M. Psychosocial factors and cell-mediated immunity. Clin Immunol Newsl 1988;9(10):157-159.

(66) Schlesinger M, Yodfat Y. Effect of psychosocial stress on natural killer cell activity. Cancer Detect Prev 1988;12(1-6):9-14.

(67) Levy J, Rabinowitz R, Schlesinger M. Binding of mouse red blood cells (MRBC) by human thymocytes: Augmentation of rosette formation by phospholipase C treatment. Isr J Med Sci 1988;24(7):335-341.

(68) Rabinowitz R, Thomas DB, Hadar R, Schlesinger M. Idiotypic determinants on monoclonal autoantibodies to the Thy-1 antigen. Immunology 1988;63(1):9-15.

(69) Katz J, Goultschin J, Benoliel R, Schlesinger M. Peripheral T lymphocyte subsets in rapidly progressive periodontitis. J Clin Periodontol 1988;15(4):266-268.

(70) Levy J, Schlesinger M, Rabinowitz R. Age-related alterations in the effect of Thy-1 antibody on autorosette formation. Transplant Proc 1987;19(1 I):279-280.

(71) Rabinowitz R, Hadar R, Laskov R, Schlesinger M. A new autoreactive monoclonal antibody specific for the Thy-1 antigen. Thymus 1986;8(5):279-294.

(72) Kleinman Y, Yust I, Maayan S, Rave D, Merdler C, Michaeli D, et al. Transmission of acquired immune deficiency syndrome (AIDS) by a blood transfusion given in 1979 in Israel. Isr J Med Sci 1986;22(5):404-407.

(73) Schlesinger M, Moreb J, Viskoper RJ, Handzel ZT, Fink A, Freier S. Is common variable hypogammaglobulinemia linked to HLA? A family study. Isr J Med Sci 1985;21(11):886-888.

(74) Levy J, Rabinowitz R, Schlesinger M. Implication of the Thy-1 antigen on mouse thymus cells in the recognition of 'self' structures. Thymus 1985;7(2):85-93.

(75) Schlesinger M, Lew F, Bekesi JG. The expression of Leu M4 on human NK cells. J Clin Lab Immunol 1985;16(1):13-16.

(76) Rabinowitz R, Levy J, Schlesinger M. The role of Lyt-2.1 determinants on mouse thymus cells in the formation of rosettes with allogeneic RBCs. Transplant Proc 1985;17(1 I):544-545.

(77) Bassat HB, Rabinowitz R, Polliack A, Hadar R, Schlesinger M. Establishment of the amsalem T‐cell line from a patient with acute lymphoblastic leukemia. Expression of E‐receptor‐associated antigens in cells incapable of forming E‐rosettes. Int J Cancer 1985;35(1):27-33.

(78) Schlesinger M, Bekesi JG. Inhibition of human natural killer activity by 2-deoxy-D-glucose and other sugars. J Clin Lab Immunol 1984;15(1):19-26.

(79) Schlesinger M, Lew F, Bekesi JG. Surface antigen determinants in subpopulations of peripheral blood NK- and T-cells separated by percoll density fractionation. J Clin Lab Immunol 1984;13(4):195-202.

(80) Schlesinger M, Haubenstock HS, Bekesi JG. E-receptors mediate the attachment of activated T-lymphocytes to human red blood cells: Evidence from studies with monoclonal antibodies and simple sugars. J Clin Lab Immunol 1984;15(1):27-33.

(81) Rabinowitz R, Levy J, Schlesinger M. Cell surface receptors involved in the attachment of murine cytotoxic T lymphocytes to target cells - a study with xenoantisera to T-cell antigens. Thymus 1983;5(3-4):127-139.

(82) Schlesinger M, Ilfeld D, Handzel ZT, Altman Y, Kuperman O, Levin S, et al. Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever. Clin Exp Immunol 1983;54(1):73-79.

(83) Schlesinger M, Levy J, Laskov R, Hadar R, Weinstock J, Ben-Bassat H, et al. The role of E receptors in the attachment of thymocytes and T lymphocytes to human target cells. Clin Immunol Immunopathol 1983;29(3):349-358.

(84) Rabinowitz R, Rachmilewitz B, Rachmilewitz M, Schlesinger M. Production of transcobalamin II by various murine and human cells in culture. Isr J Med Sci 1982;18(7):740-745.

(85) Rabinowitz R, Weinstock J, Margalioth EJ, Ben-Bassat H, Schlesinger M. Antigens specific for human T-lymphocytes detected by xenoantisera to HD-MAR cells: Their differential expression on various T-cell lines. Hum Immunol 1982;4(3):219-228.

(86) BARAK Y, MOGILNER BM, KAROV Y, NIR E, SCHLESINGER M, LEVIN S. TRANSIENT ACUTE LEUKAEMIA IN A NEWBORN WITH DOWN'S SYNDROME: Prediction of its Reversibility by Bone Marrow Cultures. Acta Paediatr Int J Paediatr 1982;71(4):699-701.

(87) Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus. Arthritis Rheum 1982;25(6):601-611.

(88) Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. ii. Arthritis Rheum 1982;25(6):612-617.

(89) Schlesinger M, Zlotnick H, Rabinowitz R, Rachmilewitz B, Rachmilewitz M. Age-related changes in the concentration of transcobalamin II (TC II) in mouse peritoneal cells. RES J RETICULOENDOTHEL SOC 1981;30(3):183-189.

(90) Schlesinger M, Rabinowitz R, Kertes T, Ravid Z, Goldblum N. Antibodies to human T lymphocytes in xenoantisera elicited with a new immature T-cell line (Peer). Thymus 1981;2(4-5):235-243.

(91) Rabinowitz R, Schlesinger M. Relationship of Ly-3 and idiotypic determinants to the T-cell receptor. Transplant Proc 1981;13(1):1147-1149.

(92) Handzel ZT, Levin S, Dolphin Z, Schlesinger M, Hahn T, Altman Y, et al. Immune competence of newborn lymphocytes. Pediatrics 1980;65(3):491-496.

(93) Rabinowitz R, Schlesinger M. Reactivity of rat antithy-1 serum with peripheral mouse T lymphocytes. Transplantation 1980;29(2):173-174.

(94) Rabinowitz R, Schlesinger M. Inhibition of the activity of cytotoxic murine T lymphocytes by antibodies to idiotypic determinants. Immunology 1980;39(1):93-99.

(95) Rabinowitz R, Laskov R, Schlesinger M. Inhibition of cell‐mediated lysis by xenoantibodies reactive with effector T lymphocytes. Eur J Immunol 1980;10(3):219-223.

(96) Rachmilewitz D, Ligumsky M, Rachmilewitz B, Rachmilewitz M, Tarcic N, Schlesinger M. Transcobalamin II level in peripheral blood monocytes-A biochemical marker in inflammatory diseases of the bowel. Gastroenterology 1980;78(1):43-46.

(97) Ravid Z, Goldblum N, Zaizov R, Schlesinger M, Kertes T, Minowada J, et al. Establishment and characterization of a new leukaemic T‐cell line (Peer) with an unusual phenotype. Int J Cancer 1980;25(6):705-710.

(98) Rabinowitz R, Laskov R, Schlesinger M. The effect of xenoantisera on T-lymphocyte functions in the absence of complement. Adv Exp Med Biol 1979;121 B:247-260.

(99) Rachmilewitz M, Rachmilewitz B, Chaouat M, Zlotnik H, Schlesinger M. The mononuclear phagocyte system and hemopoiesis. Adv Exp Med Biol 1979;121(A):419-431.

(100) Levin S, Schlesinger M, Handzel Z, Hahn T, Altman Y, Czernobilsky B, et al. Thymic deficiency in Down's syndrome. Pediatrics 1979;63(1):80-87.

(101) Schlesinger M, Kertes T. The formation of stable E rosettes by human peripheral blood lymphocytes after short exposure to concanavalin A. Clin Immunol Immunopathol 1979;12(1):1-11.

(102) Lobel S, Rabinowitz R, Schlesinger M. Mechanisms involved in the weak alloimmunogenicity of Thy-1 on mouse brain. Transplantation 1979;28(4):329-332.

(103) DIMANT J, GINZLER EM, SCHLESINGER M, DIAMOND HS, KAPLAN D. Systemic Lupus Erythematosus in the Older Age Group: Computer Analysis. J Am Geriatr Soc 1979;27(2):58-61.

(104) Dimant J, Ginzler E, Schlesinger M, Diamond GSH, Kaplan D, Weiner M. The clinical significance of raynaud's phenomenon in systemic lupus erythematosus. Arthritis Rheum 1979;22(8):815-819.

(105) Rabinowitz R, Laskov R, Schlesinger M. Antigenic properties of lymph-node cells responding to allogeneic lymphocytes and to various concentrations of lectins. Immunology 1978;34(6):959-967.

(106) Dimant J, Ginzler EM, Diamond HS, Schlesinger M, Marino CT, Weiner M, et al. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol 1978;5(2):136-141.

(107) Prebluda JL, Melmed RN, Rabinowitz R, Schlesinger M. The relationship between cholera toxin receptor and the Thy-1 antigen determinants. Isr J Med Sci 1978;14(8):876-881.

(108) Galili U, Schlesinger M. Regulation of the cytotoxic effect of human 'normal killer cells' on tumor cell lines by neuraminidase-treated T-lymphocytes. Cancer Immunol Immunother 1978;4(1):33-39.

(109) Rachmilewitz B, Rachmilewitz M, Chaouat M, Schlesinger M. Production of TCII (vitamin B12 transport protein) by mouse mononuclear phagocytes. Blood 1978;52(6):1089-1098.

(110) Schlesinger M, Handzel ZT, Reichman B, Levin S. Severe combined immune deficiency, variable type, in two sisters. Harefuah 1978;94(7-8):221-223 + 251.

(111) Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978;21(1):37-44.

(112) Galili U, Klein E, Schlesinger M. Human T lymphocyte receptors for sheep red blood cells and specific antigens: are they identical sites on the cell membrane? J Immunol 1977;119(1):104-109.

(113) Yakir Y, Kook AI, Schlesinger M, Trainin N. Effect of thymic humoral factor on intracellular levels of cyclic AMP in human peripheral blood lymphocytes. Isr J Med Sci 1977;13(12):1191-1196.

(114) Rachmilewitz B, Rachmilewitz M, Chaouat M, Schlesinger M. The synthesis of transcobalamin II, a vitamin B12 transport protein by stimulated mouse peritoneal macrophages. Biomed Express 1977;27(6):213-214.

(115) Laskov R, Rabinowitz R, Haimovitz A, Schlesinger M. Cell surface antigens as differentiation markers of the B lymphocyte lineage. Isr J Med Sci 1977;13(8):767-776.

(116) Schlesinger M. Immunological functions of the thymus. Isr J Med Sci 1977;13(4):343-346.

(117) Schlesinger M, Bekesi JG. Natural autoantibodies cytotoxic for thymus cells and for neuraminidase-treated leukemia cells in the sera of normal AKR mice. J Natl Cancer Inst 1977;59(3):945-950.

(118) Rabinowitz R, Sharav Y, Schlesinger M. Distinct properties of Thy‐1 antibodies elicited in rats by immunization with mouse brain. Eur J Immunol 1977;7(7):492-496.

(119) Udassin R, Schlesinger M, Ben-Hur N. Prolonged survival of skin grafts in mice following treatment of the donors with fractions of cell-free Ehrlich ascites fluid. European Journal of Cancer (1965) 1977;13(10):1163-1168.

(120) Galili U, Brautbar C, Schlesinger M. Association between HLA Determinants and Complement Receptors on Human Lymphocytes. Tissue Antigens 1977;10(2):99-107.

(121) Lichtenstein N, Grossowicz N, Schlesinger M. Antitumor activity of aromatic acyl derivatives of amino acids. Isr J Med Sci 1977;13(3):316-320.

(122) Rachmilewitz B, Rachmilewitz M, Chaouat M, Schlesinger M. Increased transcobalamin II, a vitamin B12 transport protein, in stimulated peritoneal cells of the mouse. Isr J Med Sci 1977;13(10):1047.

(123) Galili U, Caine M, Servadio C, Schlesinger M. Specific attachment of T-lymphocytes from cancer patients to tumor cells. Cancer Lett 1977;3(C):121-124.

(124) Ben-Zwi A, Galili U, Russell A, Schlesinger M. Age-associated changes in subpopulations of human lymphocytes. Clin Immunol Immunopathol 1977;7(1):139-149.

(125) Galili U, Schlesinger M. The formation of stable E rosettes by human T lymphocytes activated in mixed lymphocyte reactions. J Immunol 1976;117(3):730-735.

(126) Schlesinger M, Israel E, Gery I. Antigenic properties of subsets of splenic T lymphocytes responding to lectins. Immunol Commun 1976;30(6):865-872.

(127) Schlesinger M. INTRODUCTORY REMARKS. Ann New York Acad Sci 1976;276(1):276-277.

(128) Schlesinger M. Cell surface receptors and lymphocyte migration. Immunol Invest 1976;5(9):775-793.

(129) Schlesinger M. Surface properties of lymphoid cells - summing up. Adv Exp Med Biol 1976;66:159-161.

(130) Schlesinger M. Surface properties of lymphoid cells - introduction. Adv Exp Med Biol 1976;66:83-85.

(131) Schlesinger M, Levin S, Czernobilsky B, Boss J. Proceedings: Histopathological changes in the thymus in children with Down's syndrome. Isr J Med Sci 1976;12(1):79.

(132) Raben M, Walach N, Galili U, Schlesinger M. The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer 1976;37(3):1417-1421.

(133) Rotter V, Schlesinger M, Kalderon R, Trainin N. Response of human lymphocytes to PHA and con A, dependent on and regulated by THF, and thymic hormone. J Immunol 1976;17(5 (II)):1927-1932.

(134) Schlesinger M, Levin S, Handzel Z, Hahn T, Altman Y, Chernobilski B, et al. Clinical, immunological and histopathological evidence for thymic deficiency in Down's syndrome (mongolism). Adv Exp Med Biol 1976;66:665-671.

(135) Galili U, Schlesinger M. Studies on the formation of E rosettes by human T lymphocytes and thymus cells. Effects of temperature, metabolic inhibitors and anti T sera. Isr J Med Sci 1975;11(12):1357-1367.

(136) Galili U, Schlesinger M. Proceedings: Delineation of distinct subpopulations of human thymus cells. Isr J Med Sci 1975;11(12):1380-1381.

(137) Rabinowitz R, Laskov R, Schlesinger M. Proceedings: Alloantigenic characterization of responder cells in the mixed lymphocyte reaction. Isr J Med Sci 1975;11(12):1387.

(138) Lazar A, Schlesinger M, Horowitz AT, Heller E. Induction of a carcinogenic oncornavirus in C57BL/6 mouse embryo cells by 5-iododeoxyuridine. Nature 1975;255(5510):648-650.

(139) Barak V, Israel E, Schlesinger M, Gery I. Proceedings: Dissociation between subsets of murine T lymphocytes during ontogenesis and recovery from irradiation. Isr J Med Sci 1975;11(12):1381.

(140) Schlesinger M, Israël E. The recovery of spleen-seeking and lymph-node-seeking thymus subpopulations following cortisol administration. Cell Immunol 1975;18(1):144-151.

(141) Galili U, Schlesinger M. Subpopulations of hyman thymus cells differing in their capacity to form stable E rosettes and in their immunologic reactivity. J Immunol 1975;115(3):827-833.

(142) Schlesinger M, Chaouat M. The association of H‐2 antigens and EAC receptors on the surface of peritoneal cells. Eur J Immunol 1975;5(1):27-32.

(143) Galili U, Eliakim M, Slavin S, Schlesinger M. Lymphocyte subpopulations in chronic active hepatitis: Increase in lymphocytes forming stable E-rosettes. Clin Immunol Immunopathol 1975;4(4):538-544.

(144) Schlesinger M, Israel E, Chaouat M, Gery I. THE NATURE AND FUNCTION OF T‐CELL ANTIGENS. Ann New York Acad Sci 1975;249(1):505-522.

(145) Schlesinger M. The lymphocyte membrane. SER HAEMAT 1974;7(4):427-445.

(146) Galili U, Schlesinger M. The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J Immunol 1974;112(5):1628-1634.

(147) Schlesinger M, Galili U. Antigenic differences between T and B lymphocytes in man. Isr J Med Sci 1974;10(7):715-724.

(148) Schlesinger M, Chaouat M. The exposure of autoantigenic determinants on the cell surface of murine thymocytes following neuraminidase treatment. Behring Inst Mitt 1974;No. 55:216-223.

(149) Schlesinger M, Galili U. The effect of neuraminidase on the formation of E rosettes by human peripheral lymphocytes and sheep red blood cells. Behring Inst Mitt 1974;no. 55:272-276.

(150) Schlesinger M, Israël E. The effect of lectins on the migration of lymphocytes in vivo. Cell Immunol 1974;14(1):66-79.

(151) Laskov R, Rabinowitz R, Schlesinger M. Differences in the expression of a cell surface antigen among various murine myeloma tumor cells. Isr J Med Sci 1974;10(8):847-855.

(152) Rabinowitz R, Cohen A, Laskov R, Schlesinger M. Antibodies specific for the theta and Ly alloantigens in various rabbit antisera. J Immunol 1974;112(2):683-692.

(153) Schlesinger M, Chaouat M. Antibody-induced alteration in the expression of the H-2 antigenicity on murine peritoneal cells: the effect of metabolic inhibitors on antigenic modulation and antigen recovery. Transplant Proc 1973;5(1):105-110.

(154) Schlesinger M. Antigenic modulation. Biomedicine 1973;18(6):437-440.

(155) Schlesinger M, Korzash Z. Antigenic markers on lymphoid cells varying in their capacity to recirculate. Adv Exp Med Biol 1973;29:71-77.

(156) Schlesinger M, Shlomai‐Korzash Z, Israèl E. Antigenic differences between spleen‐seeking and lymph node‐seeking thymus cells. Eur J Immunol 1973;3(6):335-339.

(157) Wayne Flye M, Schlesinger M, Bernard Amos D. Cytotoxic effect of normal rabbit serum on human lymphoid cells. Transplantation 1973;16(2):117-121.

(158) Laskov R, Rabinowitz R, Schlesinger M. Antigenic characterization of murine rosette and plaque forming cells. Immunology 1973;24(6):934-954.

(159) Schlesinger M, Gottesfeld S, Korzash Z. Thymus cell subpopulations separated on discontinuous BSA gradients: Antigenic properties and circulation capacity. Cell Immunol 1973;6(1):49-58.

(160) Schlesinger M. Antigens of the thymus. Prog Allergy 1972;16:214-299.

(161) SCHLESINGER M, CHAOUAT M. Modulation of the H‐2 Antigenicity on the Surface of Murine Peritoneal Cells. Tissue Antigens 1972;2(6):427-435.

(162) Shohat B, Schlesinger M, Grossowicz N, Lichtenstein N. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids. Isr J Med Sci 1972;8(1):29-33.

(163) Schlesinger M, Grossowicz N, Lichtenstein N. Inhibition of murine tumors by carbobenzoxy derivatives of amino acids. Isr J Med Sci 1971;7(4):547-552.

(164) Schlesinger M, Amos BD. Effect of neuraminidase on serological properties of murine lymphoid cells. Transplant Proc 1971;3(1):895-897.

(165) Schlesinger M. Anti-θ antibodies for detecting thymus-dependent lymphocytes in the immune response of mice to SRBC. Nature 1970;226(5252):1254-1256.

(166) Loring M, Schlesinger M. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor. Cancer Res 1970;30(8):2204-2207.

(167) Schlesinger M, Yron I. Serologic demonstration of a thymus-dependent population of lymph-node cells. J Immunol 1970;104(4):798-804.

(168) Patinkin D, Schlesinger M, Doljanski F. A study of surface ionogenic groups of different types of normal and leukemic cells. Cancer Res 1970;30(2):489-497.

(169) Cohe A, Schlesinger M. Absorption of guinea pig serum with agar: A method for elimination of its cytotoxicity for murine thymus cells. Transplantation 1970;10(1):130-132.

(170) Schlesinger M, Cohen A, Hurvitz D. Characterization of cytotoxic isoantisera produced in RIII mice. II. Serological properties of antiserum fractions. Isr J Med Sci 1969;5(2):235-244.

(171) Schlesinger M, Yron I. Antigenic changes in lymph-node cells after administration of antiserum to thymus cells. Science 1969;164(3886):1412-1413.

(172) Schlesinger M, Hurvitz D. Characterization of cytotoxic isoantisera produced in riii mice: I. Demonstration of antibodies against the θ-C3H isoantigen. Transplantation 1969;7(2):132-141.

(173) Schlesinger M, Grossowicz N, Lichtenstein N. Anti-tumour activity of carbobenzoxy-l-asparagine. Experientia 1969;25(1):14-15.

(174) Schlesinger M, Hurvitz D. Differentiation of the thymus-leukemia (TL) antigen in the thymus of mouse embryos. Isr J Med Sci 1968;4(6):1210-1215.

(175) Robinson E, Golakai VK, Schlesinger M. Studies on the Mechanism of Prolonged Survival of Allografts from Tumor-bearing Donors. Cancer Res 1968;28(3):462-464.

(176) Schlesinger M, Hurvitz D. Serological analysis of thymus and spleen grafts. J Exp Med 1968;127(6):1127-1137.

(177) Schlesinger M, Golakai VK. Loss of thymus-distinctive serological characteristics in mice under certain conditions. Science 1967;155(3766):1114-1116.

(178) Schlesinger M, Cohen A, Hurvitz D. Inhibition by carbohydrates of the cytotoxicity of heterologous sera for mouse thymus cells. Isr J Med Sci 1966;2(5):616-619.


(180) Schlesinger M. Spontaneous occurrence of autoantibodies cytotoxic to thymus cells in the sera of mice of the 129 strain [40]. Nature 1965;207(4995):429-430.

(181) Schlesinger M, Boyse EA, Old LJ. Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells. Nature 1965;206(4989):1119-1121.

(182) Schlesinger M, Goitein R. Modification of runt disease by treatment of the donor with lyophilized tissues. J Immunol 1965;95(2):323-330.



(185) Schlesinger M, Goitein R. Effect of litter size on the induction of runt disease in mice. Transplantation 1963;1(4):481-487.

(186) Schlesinger M. Uterus of rodents as site for manifestation of transplantation immunity against transplantable tumors. J Natl Cancer Inst 1962;28(4):927-945.

(187) Pikovski M, Schlesinger M. The Transplantability of Strain-specific and Nonspecific Mouse Tumors to Pretreated Rats. Cancer Res 1959;19(2):222-226.

(188) Pikovski M, Schlesinger M. Natural Agglutinins in Rat Sera against Cells of Mouse Tumors Differing in Their Transplantability to Pretreated Rats. Cancer Res 1959;19(2):227-232.

(189) Pikovski M, Tal C, Schlesinger M, Margoliash E. Serological changes concomitant with the growth of mouse tumours in pretreated rats. Nature 1957;180(4578):185-186.

(190) Pikovski MA, Schlesinger M. Conditions Influencing the Degree of Tolerance of Mouse Tumors in Rats Pretreated with Mouse Tissue. Cancer Res 1956;16(9):848-855.

(191) Pikovski M, Schlesinger M. The Effect of Prior Injections of Lyophilized Mouse Tumor on the Growth and Transplantation of Mouse Tumors in Rats. Cancer Res 1955;15(5):285-290.